Abstract:Chemotherapy is the most popular anti-cancer therapy; however, it usually leads to severe side effects to healthy organs because of its high cytotoxicity and poor lesion selectivity. Although various smart carriers have been developed to provide beneficial properties for the local delivery of chemotherapy, it remains challenges in the efficiency and sustained release of drugs. Injectable hydrogels are more advantageous over other drug delivery systems owing to their unique properties, such as non-invasive administration, easy drug loading and locally controlled release at the target sites. Herein, "click" reaction between thiolated hyaluronic (HA–SH) and cyclodextrin–vinyl sulfone (CD–VS) has been used to formulate an injectable hydrogel system for the local delivery of an anticancer drug (Doxorubicin) to cancer cells. This strategy can rapidly induce hydrogelation, while increasing the loading, retention, and sustained release of DOX at the tumor sites through the formation of inclusion complexes between drugs and cyclodextrin. The physico-chemical features of hydrogels, such as gelation time, swelling ratio, porosity, and degradation rate were investigated by varying the concentrations of CD–VS crosslinker. The sustained and pH-sensitive release of DOX from hydrogels were also examined. Finally, the cell viability of the blank hydrogel, free DOX, and DOX-loaded hydrogel was studied by WST-1 and live/dead assay on HELA cells, which exhibited excellent biocompatibility of blank hydrogel and a dose-dependent cytotoxicity of DOX-loaded hydrogels. Therefore, this HA-based hydrogel will be a potential injectable carrier for the targeted and sustained delivery of chemotherapy drugs in cancer treatment.

Molecular Hydrogels of Hydrophobic Compounds: a Novel Self-Delivery System for Anti-Cancer Drugs

Hydrogel systems for targeted cancer therapy

Injectable hyaluronic acid–cyclodextrin-based hydrogels for localized and sustained release of anticancer drugs

A Pure Molecular Drug Hydrogel for Post-Surgical Cancer Treatment

Injectable micellar supramolecular hydrogel for delivery of hydrophobic anticancer drugs

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Injectable Hydrogels for Localized Cancer Therapy

In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment

A Novel Octa-Arginine-Modified Injectable Self-Assembling Peptide Hydrogel for Multidrug-Resistant Cancer Therapy

Empowering hydrophobic anticancer drugs by ultrashort peptides: General Co-assembly strategy for improved solubility, targeted efficacy, and clinical application

Cisplatin-activated and hemoglobin-mediated injectable hydrogel system for antitumor chemodynamic and chemotherapy

Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance

Polymer-based hydrogels with local drug release for cancer immunotherapy

Near-Infrared-Controlled, Targeted Hydrophobic Drug-Delivery System for Synergistic Cancer Therapy

An acid-labile bridged β-CD-based nano-hydrogel with superior anti-tumor drug delivery and release capacity

Fabrication of an Injectable Star-polylactide/Thiolated Hyaluronate Hydrogel as a Double Drug-Delivery System for Cancer Treatment

Regulation of Hydrophobicity of Polyphosphoester Based Drug Delivery System for Enhanced Cancer Therapy.

Application of injectable hydrogels in cancer immunotherapy

Hydrogel-Based Controlled Drug Delivery For Cancer Treatment: A Review

Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy

Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy